Navigation Links
Boston University Medical Center researcher honored
Date:12/13/2007

Boston, MAMichael F. Holick, PhD, MD, was recently awarded the 2007 Eli Lilly Lecturer Award from the Canadian Society of Endocrinology and Metabolism (CSEM). Holick, an internationally recognized expert in vitamin D and skin research, received the award for decades of pioneering work that elucidated the important role vitamin D plays in a wide variety of chronic health conditions.

Holick is a professor of medicine, physiology, and biophysics, and director of the General Clinical Research Center at Boston University School of Medicine and Director of the Bone Healthcare Clinic at Boston Medical Center.

The Eli Lilly Lecturer Award has been awarded to some of the most prominent endocrinologists in the world. CSEM represents over three hundred endocrinologists engaged in basic research or clinical practice in communities, universities and industries across Canada. They also represent the interests of their members with respect to clinical practice, academic training, research funding and medical politics.

After completing medical school at the University of Wisconsin in 1976, Holick joined the staff at the Massachusetts General Hospital where he did an internship in medicine while simultaneously initiating a basic and clinical research program on the photobiology of vitamin D. Over the next several years he made major contributions in the areas of skin disease, metabolic bone disease, and calcium metabolism.

In 1987, Holick was recruited by Boston University School of Medicine for the position of chief of endocrinology at Boston City Hospital and director of the Clinical Research Center. Since assuming this position, he has initiated numerous clinical research programs. His psoriasis work with active vitamin D is considered to be on the forefront of research into this complex disease. The results of these programs have led to significant contributions in the basic science of vitamin D and more recently into a clearer understanding of the calciotropic hormone, PTHrP and its uses. This translates into remarkable new therapies for a wide diversity of diseases from psoriasis and hair loss to osteoporosis.

Holick has received numerous honors and awards including The American Society for Clinical Nutritions McCollum Award for his innovative research in the field of photobiology in 1994, and the Psoriasis Research Achievement Award, American Skin Association in 2000, the Robert H. Herman Memorial Award in Clinical Nutrition, American Society for Clinical Nutrition 2002, and the General Clinical Research Centers Program Award for Excellence in Clinical Research in 2006 and the Functional Medicine Linus Pauling Award in 2007.


'/>"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-8491
Boston University
Source:Eurekalert

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces Amended Agreement to Settle Product Lawsuits
7. Boston Scientific Announces New Initiatives to Increase Shareholder Value
8. Boston Scientific Announces Additions to Clinical Sciences Organization
9. Boston University School of Medicine physician receives award from AATOD
10. Boston Scientific Announces Verdict in Cordis Litigation
11. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... An April 24th article on Yahoo! ... 180 pounds with the help of a weight loss surgery. The woman, declaring “I will ... that have been left following her dramatic weight loss. Dr. Feiz & Associates notes that, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider ... Online(TM), which enables sleep physicians to create and edit their interpretation reports. This ... provides a familiar interface that does not require additional training to use. It ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic ... has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board ... Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... ... cardiac or hERG liability could substantially improve drug safety and minimize the cost ... provided for validating ion channel inhibition using cell lines and for cardiac toxicity ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology: